sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Ocular Drug Delivery Market Scope And Analysis

  • Report Code : TIPRE00025781
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 145
Buy Now

Asia Pacific Ocular Drug Delivery Market Analysis, Trends, and Scope 2022 to 2028

Buy Now

Asia Pacific Ocular Drug Delivery Market Report Asia Pacific Ocular Drug Delivery Market Size and Share Asia Pacific Ocular Drug Delivery Market Scope and Analysis

Asia Pacific Ocular Drug Delivery Market Report Scope

Report Attribute Details
Market size in 2021 US$ 3,234.93 Million
Market Size by 2028 US$ 5,608.56 Million
Global CAGR (2021 - 2028) 8.2%
Historical Data 2019-2020
Forecast period 2022-2028
Segments Covered By Technology
  • Implantable Ocular Drug Delivery Systems
  • Particulate Drug Delivery Systems
  • Nano-Particle Drug Delivery System
By Formulation Type
  • Liposomes and Nanoparticles
  • Solution
  • Emulsion
  • Suspension
  • Ointment
By Disease Type
  • Glaucoma
  • Diabetic Retinopathy
  • Dry Eye Syndrome
  • Macular Degeneration
  • Cataract
  • Diabetic Macular Edema
By End User
  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • AbbVie Inc
  • Bausch Health Companies Inc
  • Novartis AG
  • Clearside Biomedical Inc
  • Taiwan Liposome Company Ltd